Advancing Clinical Care and Research with Confidence
care trends across the nation.
Advancing Clinical Care and Research with Confidence
Gain tailored insights into cardiovascular trends across the nation.
The Challenge
Patient Enrollment Is Time Consuming and Costly
egnite provides a more targeted, efficient way to conduct trials and research:
![](https://egnitehealth.com/wp-content/uploads/2023/02/Asset-2Trial-Accelerator_white.png)
Find the Right Patients
at the Right Time
Using artificial intelligence and advanced data processing to pre-screen for eligible patients
![](https://egnitehealth.com/wp-content/uploads/2023/02/module1_trial_acc_icon.png)
Streamline Enrollment
Improve efficiencies by up to 55% compared to traditional screening techniques
![](https://egnitehealth.com/wp-content/uploads/2024/03/Asset-2.png)
Discover Key Drivers
of Patient Attrition
Enhance patient and site selection
PARTNERS
![](https://egnitehealth.com/wp-content/uploads/2024/02/boston-scientific-logo-png-transparent-e1708368199151-1024x356.png)
![](https://egnitehealth.com/wp-content/uploads/2024/02/0d03b4f5-7455-4b9c-a19d-581d464f614f.png)
![](https://egnitehealth.com/wp-content/uploads/2024/02/logo.png)
The Data
Welcome to One of the Largest Ecosystems of Real-World Cardiovascular Data
![](https://egnitehealth.com/wp-content/uploads/2023/03/icons_industry_module3_EMR_white.png)
Longitudinal, echo and EHR data validated by clinicians daily
![](https://egnitehealth.com/wp-content/uploads/2023/03/icons_industry_module3_patient_white.png)
Leading-edge big data processing techniques scan over 3,000 unique data points per patient, updating data nightly
![](https://egnitehealth.com/wp-content/uploads/2023/03/icons_industry_module3_NLP_white.png)
Proprietary NLP transforms unstructured echo data into usable information
![](https://egnitehealth.com/wp-content/uploads/2023/03/icons_industry_module3_map_usa_white.png)
Geographically diverse dataset from across the U.S.
![](https://egnitehealth.com/wp-content/uploads/2023/03/icons_industry_module3_NLP_white.png)
Proprietary NLP transforms unstructured echo data into usable information
![](https://egnitehealth.com/wp-content/uploads/2023/03/icons_industry_module3_map_usa_white.png)
Geographically diverse dataset from across the U.S.
![](https://egnitehealth.com/wp-content/uploads/2023/03/icons_industry_module3_EMR_white.png)
Longitudinal, echo and EHR data validated by clinicians daily
![](https://egnitehealth.com/wp-content/uploads/2023/03/icons_industry_module3_patient_white.png)
Leading-edge big data processing techniques scan over 3,000 unique data points per patient, updating data nightly
*Data from egnite’s de-identified database of 26 teaching and non-teaching US institutions with appropriate permissions.
Our Products
egnite Therapy Accelerator
for existing therapies
![](https://egnitehealth.com/wp-content/uploads/2023/12/LAAC-Managing-Provider-List-on-Screen-1024x768.png)
![](https://egnitehealth.com/wp-content/uploads/2023/12/LAAC-Managing-Provider-List-on-Screen-1024x768.png)
for existing therapies
![](https://egnitehealth.com/wp-content/uploads/2023/06/CORCINCH-HF-Trial-Identification-Photoshopped-Version-on-mac-1024x768.png)
for clinical trials
egnite Research
Collaborate to answer contemporary questions in cardiovascular disease:
![](https://egnitehealth.com/wp-content/uploads/2023/02/Asset-5@4x.png)
Heart
Failure
![](https://egnitehealth.com/wp-content/uploads/2023/02/Afib-Icon.png)
Atrial
Fibrillation
![](https://egnitehealth.com/wp-content/uploads/2023/02/Asset-7@4x.png)
Mitral
Regurgitation
![](https://egnitehealth.com/wp-content/uploads/2023/02/Asset-9@4x.png)
Mitral
Stenosis
![](https://egnitehealth.com/wp-content/uploads/2023/02/Asset-7@4x.png)
Tricuspid
Regurgitation
![](https://egnitehealth.com/wp-content/uploads/2023/02/Asset-8@4x.png)
Aortic
Regurgitation
![](https://egnitehealth.com/wp-content/uploads/2023/02/Asset-6@4x.png)
Aortic
Stenosis
Presented or Published In
![](https://egnitehealth.com/wp-content/uploads/2023/02/module3_tct_logo.png)
![](https://egnitehealth.com/wp-content/uploads/2023/02/module3_acc_logo.png)
![](https://egnitehealth.com/wp-content/uploads/2024/02/CRF-TVT.png)
![](https://egnitehealth.com/wp-content/uploads/2024/02/HeartRhythmSocietylogo2020_b2979fc4-1560-4281-b84e-b2d1e759fde2-prv-1024x480.jpg)
![](https://egnitehealth.com/wp-content/uploads/2024/03/JACC-1024x190.png)
![](https://egnitehealth.com/wp-content/uploads/2024/03/IBM-logo.png)
![](https://egnitehealth.com/wp-content/uploads/2024/03/JASE.png)
![](https://egnitehealth.com/wp-content/uploads/2024/03/Screenshot-2024-03-07-161407.png)
Testimonials
Leading life sciences organizations partner with egnite to expand the boundaries of research and care.
![](https://egnitehealth.com/wp-content/uploads/2024/02/Duane-Pinto_BW-e1708973270253.png)
JenaValve
![](https://egnitehealth.com/wp-content/uploads/2024/02/Mark-Miles-scaled-e1708973500364.jpg)
Ancora Heart
Resources
![IMG_7272 IMG_7272](https://egnitehealth.com/wp-content/uploads/2024/04/IMG_7272-scaled.webp)
egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.
![A24090-ACC24-General-Web-625×350-moleculeNOlogo A24090-ACC24-General-Web-625x350-moleculeNOlogo](https://egnitehealth.com/wp-content/uploads/2024/04/A24090-ACC24-General-Web-625x350-moleculeNOlogo-jpg-e1712184344460.webp)
Mortality Burden for Patients with Untreated Aortic Regurgitation
“This research underscores the poor outcomes for patients with moderate AR who exhibit cardiac damage, stressing the need to monitor for distinct characteristics in this population. These insights may also prompt a reassessment of our management strategies and suggest a shift in our approach to intensified follow-up for both moderate and severe AR patients.” Philippe Généreux, […]
![MAB Announcement_2024_v.2_WEB MAB Announcement_2024_v.2_WEB](https://egnitehealth.com/wp-content/uploads/2024/03/MAB-Announcement_2024_v.2_WEB.png)
egnite, Inc. Announces the Appointment of Vinod Thourani and Nicholas Amoroso to Its Medical Advisory Board
egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.